XS
XBI icon

XR Securities’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

XR Securities’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,500
Closed -$247K – 171
2024
Q3 		$247K Sell
2,500
-6,000
-71% -$590K 0.07% 155
2024
Q2 		$788K Buy
8,500
+3,000
+55% +$269K 0.14% 110
2024
Q1 		$522K Sell
5,500
-14,900
-73% -$1.38M 0.02% 201
2023
Q4 		$1.82M Buy
20,400
+7,500
+58% +$557K 0.07% 120
2023
Q3 		$942K Buy
12,900
+2,300
+22% +$184K 0.07% 172
2023
Q2 		$882K Sell
10,600
-7,800
-42% -$652K 0.04% 173
2023
Q1 		$1.4M Buy
18,400
+6,700
+57% +$556K 0.04% 151
2022
Q4 		$971K Sell
11,700
-44,200
-79% -$3.58M 0.09% 170
2022
Q3 		$462K Buy
55,900
+33,700
+152% +$2.84M 0.25% 77
2022
Q2 		$324K Sell
22,200
-14,500
-40% -$1.09M 0.11% 127
2022
Q1 		$199K Buy
36,700
+26,100
+246% +$2.41M 0.03% 164
2021
Q4 		$250K Buy
10,600
+500
+5% +$60.3K 0.02% 191
2021
Q3 		$155K Sell
10,100
-10,200
-50% -$1.31M 0.07% 211
2021
Q2 		$161K Sell
20,300
-1,400
-6% -$184K 0.07% 212
2021
Q1 		$316K Buy
+21,700
New +$3.25M 0.02% 139
2020
Q2 		– Sell
-18,400
Closed -$147K – 324
2020
Q1 		$147K Sell
18,400
-23,700
-56% -$2.1M 0.01% 131
2019
Q4 		$21K Buy
42,100
+22,600
+116% +$1.95M ﹤0.01% 197
2019
Q3 		$120K Sell
19,500
-2,100
-10% -$175K 0.02% 137
2019
Q2 		$51K Sell
21,600
-30,500
-59% -$2.6M 0.01% 181
2019
Q1 		$21K Buy
52,100
+38,000
+270% +$3.23M ﹤0.01% 223
2018
Q4 		$92K Sell
14,100
-28,800
-67% -$2.32M 0.04% 173
2018
Q3 		$17K Buy
+42,900
New +$4.16M ﹤0.01% 299

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

XR Securities's XBI Position: Q3 2024 in Review

XR Securities sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2024, closing a stake of 5,872 shares — an estimated $577K sold.

XR Securities first reported a position in XBI in Q4 2018 and held it in 16 quarters. The position peaked at $2.22M in Q3 2022. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

  • XR Securities reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2024 after selling out during the quarter.
  • XR Securities sold 5,872 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $577K.
  • XR Securities first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and held it in 16 quarters.
  • XR Securities's State Street SPDR S&P Biotech ETF position peaked at $2.22M in Q3 2022.
  • 769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on XR Securities's 13F filing for Q3 2024, filed 25 Oct 2024.